Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | AMGN | BMY | GILD | MRNA |
| Company | Biomarin Pharmaceuticals | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 84.80 | 313.39 | 43.90 | 65.51 | 125.00 |
| High | 84.80 | 322.60 | 44.33 | 65.53 | 126.40 |
| Low | 82.32 | 308.68 | 43.69 | 64.33 | 122.01 |
| Last | 82.44 | 311.29 | 43.99 | 64.78 | 125.00 |
| Change | -1.36 | +32.90 | +0.29 | -0.55 | -0.59 |
| % Change | -1.62% | +11.82% | +0.66% | -0.84% | -0.47% |
| Volume | 1,632,800 | 9,644,601 | 12,104,400 | 7,822,700 | 4,513,100 |
| 20-Day Average Volume | 1,984,395 | 2,646,885 | 14,464,405 | 7,406,455 | 3,564,715 |
| Previous Close | 83.80 | 278.39 | 43.70 | 65.33 | 125.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 87.50 | 272.27 | 47.46 | 66.88 | 108.49 |
| 20-Day Raw Stochastic | 15.09% | 81.73% | 7.87% | 8.01% | 87.09% |
| 20-Day Relative Strength | 41.17% | 72.10% | 29.25% | 30.11% | 68.06% |
| Weighted Alpha | -15.21 | +33.76 | -36.67 | -22.64 | +8.40 |
| Today's Opinion | 72% Sell | 24% Buy | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 72% Sell | 16% Sell | 88% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 64% Sell | 24% Sell | 8% Sell | 100% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.89% since 04/26/24 | +15.30% since 04/26/24 | -1.92% since 04/26/24 | -0.98% since 04/26/24 | +15.77% since 04/26/24 |
| Low | 80.50 on 05/01/24 | 268.99 on 04/29/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 108.72 on 04/29/24 |
| High | 85.04 on 05/02/24 | 322.60 on 05/03/24 | 45.38 on 04/29/24 | 66.91 on 04/29/24 | 128.81 on 05/02/24 |
| 1-Month | |||||
| %Chg | -5.00% since 04/03/24 | +13.44% since 04/03/24 | -15.70% since 04/03/24 | -8.62% since 04/03/24 | +23.51% since 04/03/24 |
| Low | 80.50 on 05/01/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 99.30 on 04/22/24 |
| High | 93.36 on 04/15/24 | 322.60 on 05/03/24 | 52.08 on 04/04/24 | 71.39 on 04/04/24 | 128.81 on 05/02/24 |
| 3-Month | |||||
| %Chg | -6.44% since 02/02/24 | -3.68% since 02/02/24 | -9.69% since 02/02/24 | -15.83% since 02/02/24 | +28.21% since 02/02/24 |
| Low | 80.50 on 05/01/24 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 84.06 on 02/13/24 |
| High | 94.15 on 02/23/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 77.87 on 02/06/24 | 128.81 on 05/02/24 |
| 6-Month | |||||
| %Chg | +3.58% since 11/03/23 | +15.35% since 11/03/23 | -16.72% since 11/03/23 | -20.60% since 11/03/23 | +61.23% since 11/03/23 |
| Low | 76.19 on 11/06/23 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 67.62 on 11/13/23 |
| High | 99.56 on 12/14/23 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 128.81 on 05/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 15,911,945 | 149,321,728 | 88,584,272 | 81,340,888 | 48,085,900 |
| Shares Outstanding, K | 189,880 | 536,376 | 2,027,100 | 1,245,077 | 382,880 |
| Annual Sales | 2,419,230,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | 167,650,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 648,830,000 | 8,196,000,000 | 11,865,000,000 | 6,686,000,000 | 2,811,000,000 |
| Last Quarter Net Income | 88,660,000 | 767,000,000 | -11,911,000,000 | -4,170,000,000 | 217,000,000 |
| 60-Month Beta | 0.34 | 0.60 | 0.45 | 0.22 | 1.57 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.71 on 04/24/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | -3.07 on 05/02/24 |
| Latest Earnings Date | 04/24/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 61.73 | 14.87 | 42.10 | 16.26 | 0.00 |